期刊文献+

B7-H4在膀胱癌肿瘤中表达的临床意义 被引量:3

The clinical significance of B7-H4 expression in bladder cancer
原文传递
导出
摘要 目的 探讨B7-H4在膀胱癌组织中的表达及其与临床病理和预后的关系.方法 以酶联免疫反应检测2007年3月至2008年3月确诊的30例膀胱癌患者外周血中sB7-H4蛋白的含量,以正常人和膀胱良性肿瘤患者外周血中的sB7-H4含量为对照.以实时荧光定量PCR(real timePCR)检测30例膀胱癌新鲜组织中B7-H4 mRNA相对表达量,以癌旁组织和膀胱良性组织为对照.免疫组化染色法检测70例膀胱癌患者手术切除组织标本中B7-H4的表达水平.结果 sB7-H4蛋白在膀胱癌患者外周血中的含量[(45.25±8.93)μg/L]明显高于膀胱良性肿瘤患者[(34.41 ±6.91) μg/L]和正常人群(31.20±6.28) μg/L(P<0.01).B7-H4 mRNA在30例膀胱癌组织和癌旁组织中均有表达,膀胱癌组织中表达明显高于癌旁组织(P<0.01),且癌旁组织中的表达明显高于膀胱良性肿瘤组织(P<0.01).70例膀胱癌组织中B7-H4蛋白阳性表达率为69%,其中77%为高表达,明显高于膀胱良性肿瘤组织(P<0.01).B7-H4蛋白的表达与膀胱癌TNM分期和远处转移密切相关(P<0.05),与患者性别、年龄、组织类型、临床分期无关(P>0.05).B7-H4高表达患者生存率明显低于低表达患者(P<0.05).结论 B7-H4在膀胱癌组织表达状态与膀胱癌的转移及预后关系密切,可以作为反映膀胱癌生物学行为和判断预后的有效指标. Objective To investigate the expression of B7-H4 and its clinical pathological characteristics in bladder cancer tissue and its relationship with the prognosis in bladder cancer patients.Methods From March 2007 to March 2008,30 patients with bladder cancer were recruited.B7-H4 protein in serum was detected by enzyme immunoassay (ELISA) while the content of B7-H4 protein in the serun of patients with bladder benign tumors and the normal population were detected as control.The expression of B7-H4 mRNA was detected in the fresh tissues of 30 patients with bladder cancer by real time quantitative PCR and the expression of B7-H4 mRNA in the adjacent tissues of bladder cancer and bladder benign tumors were detected as control.The B7-H4 expression levels in the tissue samples of 70 patients with bladder cancer was detected by immunohistochemical staining.Results B7-H4 protein [(45.25±8.93) μg/L] in serum of bladder cancer patients was significantly higher than those with bladder benign tumors [(34.41±6.91)μg/L] as well as the normal tissue [(31.20±6.28)μg/L] (P<0.01).B7-H4 mRNA expression in bladder cancer tissue was significantly higher than that of the adjacent tissue of bladder cancer (P<0.01),and the expression of B7-H4 mRNA in the adjacent tissues of bladder cancer was significantly higher than that of the bladder benign tumors (P<0.01).The positive rate of B7-H4 protein in 70 cases of bladder cancer tissues was 69%,including 77% highly expressed.The positive rate in bladder cancer patients was significantly higher than that of the bladder benign tissue (P<0.01).The expression of B7-H4 protein were significantly correlated with TNM classification and distant metastasis of bladder cancer (P<0.05),but no significant difference was detected in term of gender,age,histological type,clinical stage (P>0.05).The survival rate of the patients with highly B7-H4 expression was lower than those with low B7-H4 expression (P < 0.05).Conclusions The expression of B7-H4 in bladder cancer was correlated with the metastasis and prognosis,and B7-H4 could be used as an indicator of the biological behavior of bladder cancer and the prognosis.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2014年第2期143-146,共4页 Chinese Journal of Urology
关键词 膀胱肿瘤 B7-H4分子 预后 肿瘤转移 Bladder tumor B7-H4 molecule Prognosis Tumor metastasis
  • 相关文献

参考文献16

  • 1Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [ J ]. Immunity, 2003, 18: 849-861.
  • 2Shang Y, Guo G, Cui Q, et al. The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovi- um [J]. Inflammation, 2012, 35: 1102-12.
  • 3Chen C, Zhu YB, Shen Y, et al. Increase of circulating B7-H4- expressing CD68+ macrophage correlated with clinical stage of lung carcinomas [J]. J Immunother, 2012, 35: 354-358.
  • 4Yigit R, Massuger LF, Figdor CG, et al. Ovarian cancer creates a suppressive microenvironment to escape immune elimination [J]. Gynecol Oncol, 2010, 117: 366-372.
  • 5Jung SG, Choi KU, Lee SD, et al. The relationship between BT- H4 expression and clinicopathological characteristics in clinical stage T1 conventional renal cell carcinoma [ J]. Korea. J Urol, 2011, 52: 90-95.
  • 6Guo BH, Feng Y, Zhang R, et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an ad- vanced stage of breast cancer [J]. Mol Cancer, 2011, 10: 10- 18.
  • 7Martina MM, Nader N. The role of coinhibitory signaling path- ways in transplantation and tolerance [ J]. Front Immunol, 2012, 3: 47.
  • 8Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity [J]. J Immunother, 2007, 30: 251-260.
  • 9黄世勇,朱绍兴,连学坚,朱德胜.B7-H1与肾癌免疫治疗[J].中华泌尿外科杂志,2010,31(3):213-215. 被引量:5
  • 10He C, Qiao I-I, Jiang H, et al. The inhibitory role of b7-h4 in an- titumor immunity: association with cancer progression and surviv- al [ J]. Clin Dev Immunol, 2011, 2011: 695834.

二级参考文献25

  • 1Wintterle S,Schreiner B,Mitsdoerffer M,Schneider D,Chen,Meyermann R,Weller M,Wiendl H.Expression of the B7 - related molecule B7 - H1 by glioma cells: a potential mechanism of immune paralysis[J].中国神经肿瘤杂志,2003,1(4):241-241. 被引量:37
  • 2Haidong Dong,Xianming Chen.Immunoregulatory Role of B7-H1 in Chronicity of Inflammatory Responses[J].Cellular & Molecular Immunology,2006,3(3):179-187. 被引量:25
  • 3SICA G L,CHOI I H,ZHU G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18 (6):849 -861.
  • 4PRASAD D V,RICHARDS S,MAI X M,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
  • 5ZANG X,LOKE P,KIM J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci USA,2003,100 (18):10388-10392.
  • 6AUNOBLE B,SANCHES R,DIDIER E,et al.Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review)[J].Int J Oncol,2000,16(3):567-576.
  • 7NICOSIA S V,BAI J,CHENG Q,et al.Oncogenic pathways implicated in ovarian epithelial cancer[J].Hematol Oncol Clin North Am,2003,17(4):927-943.
  • 8SALCEDA S,TANG T,KMET M,et al.The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation[J].Exp Cell Res,2005,306(1):128-141.
  • 9KOUREA H P,BILSKY M H,LEUNG D H,et al.Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors:a clinicopatholgic study of 25 patients and 26 tumors[J].Cancer,1998,82:2191-2203.
  • 10OHORI M.Biomarkers for prostate cancer in predicting diagnosis,staging and prognosis[J].Gan To Kagaku Ryoho,2009,36(1):6.

共引文献15

同被引文献26

  • 1周四维.浅表性膀胱癌规范化治疗现状与前景[J].现代泌尿外科杂志,2005,10(6):311-313. 被引量:13
  • 2Lee SJ, Cho SC, Lee EJ, et al. Intedeukin -20 promotes migration of bladder cancer cells thmugl'l extracellular signal - regulated kinase (ERK) - mediated MMP -9 protein expression leading to nuclear factor ( NF - KB) activation by inducing the up - regulation of p21 ( WAF1 ) protein expression[ J]. J Biol Chem,2013,288(8) :5539 -5552.
  • 3Reid CN, Stevenson M, Aboguarin F, et al. Standardization of diagnostic biomarker concentrations in arine : the hematuria caveat [ J ]. PLoS One,2012,7(12) :e53354.
  • 4Willson TD, Revesz E, Podbielski FJ, et al. Unusual findings in a be- nign urachal tumor[ J]. Am Surg, 2013,79 (2) : E76 - E77.
  • 5Freifeld Y, Dekel Y, Stein A. Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC [ J ]. Curr Urol Rep,2013,14(2) :71 - 77.
  • 6彭紫元,纪梓良,张琼丽,等.CD4+CD25+调节性T细胞在膀胱癌中的分布及其临床意义[J].中华临床医师杂志(电子版),2013,(11):4844-4848.
  • 7Donnelly ED, Rakhra S, Helenowski I, et al. Dosimetry and toxicity outcomes in postoperative high - dose - rate intracavitary brachytherapy for endometrial carcinoma[ J]. J Cnntemp Brachytherapy. 2012 ;4(3 ) : 135 - 140.
  • 8Zhang G, Chen F, Cao Y, et al. HMGB1 release by urothelial carcino- ma cells in response to Bacillus Calmette - Gu6rin functions as a parac- fine factor to potentiate the direct cellular effects of Bacillus Calmette - Gu6rin[J].J Urol.2013.190 (3) : 1076 - 1082.
  • 9黄思毅,曾钦凤.HE4 CA125和sB7-H4联合检测在卵巢癌早期诊断的临床价值[J].河北医学,2011,17(4):443-445. 被引量:13
  • 10李继红,王利,吴丽娟,陈莉.甘露聚糖肽对COPD患者淋巴细胞免疫活性的影响[J].国际检验医学杂志,2011,32(20):2321-2322. 被引量:12

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部